NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against KBR, Inc. (“KBR” or “the Company”) (NYSE: KBR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired KBR securities between M ...

Core Points - The Gross Law Firm has issued a notice to shareholders of Fluor Corporation regarding a class action lawsuit related to misleading statements made by the company during a specified class period [1][2] - The class period for the lawsuit is from February 18, 2025, to July 31, 2025, during which it is alleged that Fluor Corporation failed to disclose significant cost increases and other negative impacts on its business [2][3] - Shareholders are encouraged to register for participation in the class action, with a deadline for lead plaintiff applications set for November 14, 2025 [3] Allegations - The complaint alleges that Fluor Corporation's costs for infrastructure projects were increasing due to subcontractor design errors, price hikes, and scheduling delays [2] - It is claimed that these issues, along with reduced capital spending from customers and economic uncertainty, were likely to have a significant negative impact on the company's financial results [2] - The financial guidance provided by Fluor for FY 2025 is described as unreliable, with overstated risk mitigation strategies and understated impacts of economic uncertainty [2] Next Steps for Shareholders - Shareholders who purchased shares during the class period are advised to register for the class action to receive updates on the case [3] - There is no cost or obligation for shareholders to participate in the case [3] About the Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4]

Core Viewpoint - A federal securities fraud class action lawsuit has been filed against LifeMD, alleging misleading representations regarding its financial health and growth prospects, following a significant stock price decline after its earnings report in August 2025 [1][7]. Summary by Relevant Sections Lawsuit Details - The lawsuit, titled Johnston v. LifeMD, Inc., covers the period from May 7 to August 5, 2025, claiming that LifeMD made false statements, particularly during its first-quarter results announcement on May 6, 2025, when it raised its full-year revenue and adjusted EBITDA guidance [5][6]. - The complaint asserts that LifeMD's optimistic outlook regarding its competitive position in virtual obesity care and performance from its RexMD brand was misleading, as it did not disclose significant operational challenges [5][6]. Financial Performance and Stock Impact - LifeMD reportedly faced rising customer acquisition costs in its RexMD segment and a higher-than-expected refund rate in its weight management business, which were not disclosed to investors [6]. - The situation escalated on August 5, 2025, when LifeMD announced second-quarter results that missed revenue and earnings per share estimates, leading to a drastic reduction in its full-year guidance. Following this announcement, the company's stock price dropped by over 44% [7]. Investor Actions - The lawsuit provides an opportunity for investors who incurred substantial losses during the specified period to seek recovery [8]. - Hagens Berman, the law firm investigating the claims, is looking into whether LifeMD was aware of but failed to disclose key operational issues [10].

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cybin Inc. (“Cybin” or the “Company”) (NYSE: CYBN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cybin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] We are investigating Cybin ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving PACS Group, Inc. and its officers or directors [1] Group 1: Company Developments - On September 8, 2025, PACS announced the resignation of Chief Financial Officer Derick Apt due to allegations of accepting high-value items from associated individuals, which violated company policies [3] - Following the announcement of the CFO's resignation, PACS's stock price dropped by $3.29 per share, a decline of 29.08%, closing at $8.03 per share on September 9, 2025 [3] Group 2: Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a history of recovering multimillion-dollar damages for victims of securities fraud and corporate misconduct [4]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Freeport-McMoran Inc. and its officers or directors [1]. Group 1: Company Operations - On September 9, 2025, Freeport announced the suspension of mining activities at its Grasberg Block Cave operation in Indonesia due to a blockage caused by wet material, which trapped seven workers [3]. - Following the announcement, Freeport's stock price decreased by $2.80 per share, representing a decline of 5.99%, closing at $43.87 per share on the same day [3]. Group 2: Legal Investigation - Pomerantz LLP is reaching out to investors of Freeport to gather claims related to the investigation of potential securities fraud [1]. - The firm has a long history in corporate, securities, and antitrust class litigation, having recovered numerous multimillion-dollar damages awards for victims of securities fraud and corporate misconduct [4].

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lesaka Technologies, Inc. (“Lesaka” or the “Company”) (NASDAQ: LSAK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lesaka and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Sep ...

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Galiano Gold Inc. (“Galiano” or the “Company”) (NYSE: GAU).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galiano and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On September 9, ...

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Celanese Corporation (“Celanese” or the “Company”) (NYSE: CE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Celanese and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On November ...

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether aTyr and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On September 15, 2 ...